Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial (Q33999757)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

0 references

0 references

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

10

object named as

M Laakso

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Markolf Hanefeld

8

object named as

M Hanefeld

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

ORCID Public Data File 2021

14

object named as

R R Holman

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

H C Gerstein

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

S Yusuf

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J Bosch

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J Pogue

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P Sheridan

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

N Dinccag

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

B Hoogwerf

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

V Mohan

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J Shaw

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

B Zinman

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

368

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9541

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1096-1105

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Worst-rank score analysis with informatively missing observations in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fat in the liver and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

TZDs and diabetes: testing the waters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969420-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)69420-8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33999757&oldid=1766341067"